Cypress Capital Management (Wyoming)’s Quest Diagnostics DGX Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127K	Hold	600	–	–	0.11%	69
2026 Q1	$118K	Hold	600	–	–	0.11%	67
2025 Q4	$104K	Hold	600	–	–	0.1%	67
2025 Q3	$114K	Hold	600	–	–	0.11%	65
2025 Q2	$108K	Hold	600	–	–	0.12%	60
2025 Q1	$102K	Hold	600	–	–	0.12%	62
2024 Q4	$90.5K	Hold	600	–	–	0.1%	64
2024 Q3	$93.2K	Sell	600 -165	-22%	-$24.6K	0.1%	64
2024 Q2	$105K	Hold	765	–	–	0.11%	61
2024 Q1	$102K	Hold	765	–	–	0.11%	59
2023 Q4	$105K	Hold	765	–	–	0.12%	61
2023 Q3	$93.2K	Hold	765	–	–	0.11%	60
2023 Q2	$108K	Hold	765	–	–	0.12%	56
2023 Q1	$108K	Hold	765	–	–	0.13%	55
2022 Q4	$120K	Sell	765 -235	-24%	-$33.8K	0.15%	52
2022 Q3	$123K	Hold	1,000	–	–	0.17%	46
2022 Q2	$133K	Hold	1,000	–	–	0.17%	47
2022 Q1	$137K	Hold	1,000	–	–	0.16%	54
2021 Q4	$173K	Hold	1,000	–	–	0.15%	75
2021 Q3	$145K	Hold	1,000	–	–	0.12%	83
2021 Q2	$132K	Hold	1,000	–	–	0.1%	99
2021 Q1	$128K	Hold	1,000	–	–	0.11%	93
2020 Q4	$119K	Hold	1,000	–	–	0.1%	96
2020 Q3	$117K	Hold	1,000	–	–	0.11%	89
2020 Q2	$114K	Hold	1,000	–	–	0.11%	89
2020 Q1	$80K	Hold	1,000	–	–	0.11%	78
2019 Q4	$107K	Hold	1,000	–	–	0.1%	85
2019 Q3	$107K	Hold	1,000	–	–	0.13%	78
2019 Q2	$102K	Hold	1,000	–	–	0.12%	86
2019 Q1	$90K	Hold	1,000	–	–	0.12%	88
2018 Q4	$83K	Hold	1,000	–	–	0.16%	95
2018 Q3	$108K	Hold	1,000	–	–	0.11%	117
2018 Q2	$110K	Hold	1,000	–	–	0.12%	113
2018 Q1	$100K	Hold	1,000	–	–	0.11%	106
2017 Q4	$98K	Hold	1,000	–	–	0.11%	122
2017 Q3	$94K	Hold	1,000	–	–	0.11%	113
2017 Q2	$111K	Hold	1,000	–	–	0.13%	95
2017 Q1	$98.2K	Hold	1,000	–	–	0.12%	97
2016 Q4	$92.8K	Hold	1,000	–	–	0.1%	99
2016 Q3	$84.6K	Hold	1,000	–	–	0.11%	96
2016 Q2	$81.4K	Hold	1,000	–	–	0.11%	86
2016 Q1	$71.5K	Hold	1,000	–	–	0.1%	93
2015 Q4	$71.1K	Hold	1,000	–	–	0.09%	99
2015 Q3	$61.5K	Hold	1,000	–	–	0.08%	103
2015 Q2	$72.5K	Hold	1,000	–	–	0.08%	116
2015 Q1	$76.8K	Hold	1,000	–	–	0.09%	105
2014 Q4	$67.1K	Buy	+1,000	New	+$63.1K	0.09%	99

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s DGX Position: Q2 2026 in Review

Cypress Capital Management (Wyoming) held its Quest Diagnostics (DGX) position steady in Q2 2026 at 600 shares worth $127K. The position accounts for 0.11% of the portfolio, ranked #69.

Cypress Capital Management (Wyoming) first reported a position in DGX in Q4 2014 and has held it in 47 quarters since. The position peaked at $173K in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Cypress Capital Management (Wyoming) held 600 shares of Quest Diagnostics worth $127K as of Q2 2026.
Cypress Capital Management (Wyoming) left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.11% of Cypress Capital Management (Wyoming)'s portfolio in Q2 2026, its #69 holding.
Cypress Capital Management (Wyoming) first reported a position in Quest Diagnostics in Q4 2014 and has held it in 47 quarters since.
Cypress Capital Management (Wyoming)'s Quest Diagnostics position peaked at $173K in Q4 2021.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.